Anke Janssen

Title: Anke Janssen: Innovator in Cellular Therapy

Introduction

Anke Janssen, a prominent inventor based in Utrecht, Netherlands, has made significant contributions to the field of cellular therapy. With two patents to her name, she is recognized for her pioneering methods that target anti-tumor and anti-infection responses using T-cell receptor chains.

Latest Patents

Janssen's latest inventions focus on the identification of δT-cell and γT-cell receptors. Her patents detail methods for identifying amino acid sequences of these receptors that mediate effective immune responses. These methods are crucial for advancing treatments related to tumors and infections, offering promising avenues for future therapies.

Career Highlights

During her career, Anke has worked with notable institutions, including UMC Utrecht Holding B.V. and Gadeta B.V. Her experiences at these companies have enriched her expertise and allowed her to innovate in the area of cell therapy.

Collaborations

Throughout her journey, Anke has collaborated with esteemed professionals in her field, including Jürgen Herbert Ernst Kuball and Dennis Beringer. These collaborations have not only fostered innovative ideas but have also strengthened research efforts aimed at improving cellular therapies.

Conclusion

Anke Janssen's contributions to the field of cellular therapy stand as a testament to her innovative spirit and dedication to advancing medical science. With her patents focusing on critical methods for identifying T-cell receptors, she is poised to impact future treatments for cancer and infectious diseases significantly.